Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2025-12-26 @ 2:53 PM
Study NCT ID:
NCT01832259
Status:
COMPLETED
Last Update Posted:
2018-12-12
First Post:
2013-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection
Sponsor:
University of Utah
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2017-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-21
First Submit QC Date:
None
Study First Post Date:
2013-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-09
Results First Submit QC Date:
None
Results First Post Date:
2018-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-11
Last Update Post Date:
2018-12-12
Last Update Post Date Type:
ACTUAL